Related Experiment Videos
The evolution of (99m)Tc-NGA as a clinically useful receptor-binding radiopharmaceutical
1Department of Radiology, University of California, Davis Medical Center, Sacramento, CA, USA. robert.stadalnik@ucdmc.ucdavis.edu
Nuclear Medicine and Biology
|August 23, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Next generation of radiotracers for sentinel lymph node biopsy: What is still necessary to establish new imaging paradigms?
Revista espanola de medicina nuclear e imagen molecular·2018
[(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection.
Nuclear medicine and biology·2001
A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2001
Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2001
Portal-Systemic shunts reduce asialoglycoprotein receptor density in rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2001
Research progress on the development and clinical translation of αvβ6-targeted radiopharmaceuticals.
Nuclear medicine and biology·2026
Preclinical comparison of [111In]In-BPAMD and [99mTc]Tc-DPD for SPECT/CT-based bone imaging.
Nuclear medicine and biology·2026
Reducing renal radioactivity of radiolabeled tetravalent RGD peptides via cleavable linkers for targeted radionuclide therapy.
Nuclear medicine and biology·2026
[Current Status and Challenges in the Regulation of Weight Management Medical Devices].
Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Mannose-decorated nanostructured lipid carriers improve the intracellular activity of antitubercular drugs against Mycobacterium tuberculosis.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Poly (Lipoic Acid) Nanoparticles With High Blood-Brain Barrier Permeability and Enhanced Anti-Ferroptotic Activity for Ischemic Stroke Treatment.
Small (Weinheim an der Bergstrasse, Germany)·2026